Mianserin Hydrochloride

Spezifikationen

21535-47-7CAS-Nummer

244-426-7EG-Nummer

5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene;hydrochlorideIUPAC-Name

C18H21ClN2Chemische Formel

300.8 g/molMolekulargewicht

Mianserin hydrochloride; 21535-47-7; Mianserin HCl; Bolvidon; Mianserine hydrochloride; ORG GB 94; Tetramide; 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine hydrochloride; ORG-GB 94; NSC-759590; DTXSID30944145; 2X03TN217S; CHEBI:31843; Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, monohydrochloride; 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)-pyrazino(1,2-a)azepine monohydrochloride; 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine hydrochloride; 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]-pyrazino[1,2-a]azepine monohydrochloride; Hydrochloride, Mianserin; RefChem:925840; Mianserin Monohydrochloride; Monohydrochloride, Mianserin; DTXCID601372498; 244-426-7; Athymil; Mianserin (hydrochloride); MFCD00055072; MLS000069681; Mianserin.HCl; 2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine hydrochloride; Lerivon; 5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene;hydrochloride; SMR000058472; Tolvin; mianserine HCl; 78644-54-9; Mianserin Hydrocloride; SR-01000000185; ORG GB-94 HCl; GB 94; Tetramide (TN); Prestwick_514; EINECS 244-426-7; Mianserin hydrochloride [USAN:JAN]; Mianserin hydrochloride?; (.+-.)-Athymil; Opera_ID_1505; (.+-.)-Norval; Epitope ID:768751; Mianserin hydrochloride CRS; MLS001148213; MLS002222220; SCHEMBL340474; SPECTRUM2300292; UNII-2X03TN217S; CHEMBL544428; HY-B0188AR; orb1310297; orb3141236; SCHEMBL29366576; HY-B0188A; MSK10904A; YNPFMWCWRVTGKJ-UHFFFAOYSA-N; HMS1568C20; HMS5079J17; Pharmakon1600-02300292; Mianserin HCl - Bio-X trade mark; Mianserin hydrochloride (JAN/USAN); MIANSERIN HYDROCHLORIDE [MI]; Tox21_500744; CCG-39108; EBC-11139; HB1658; Mianserin (hydrochloride) (Standard); Mianserin for system suitability CRS; MIANSERIN HYDROCHLORIDE [JAN]; NSC292267; NSC759590; s1382; MIANSERIN HYDROCHLORIDE [USAN]; AKOS015902308; CS-2079; FM25996; KS-5096; LP00744; MIANSERIN HYDROCHLORIDE [MART.]; NSC 759590; NSC-292267; MIANSERIN HYDROCHLORIDE [WHO-DD]; NCGC00094086-01; NCGC00094086-02; NCGC00094086-03; NCGC00094086-04; NCGC00261429-01; AC-25005; BM166416; SY107357; DB-045611; EU-0100744; M2623; NS00084235; SW196707-3; MIANSERIN HYDROCHLORIDE [EP MONOGRAPH]; C74052; D01358; M 2525; F862333; Mianserin.HCl, 1mg/ml in Methanol (as free base); SR-01000000185-2; SR-01000000185-4; SR-01000000185-8; Q27114695; Mianserin Hydrochloride 1.0 mg/ml in Methanol (as free base); Mianserin hydrochloride, analytical standard, for drug analysis; Mianserin hydrochloride, European Pharmacopoeia (EP) Reference Standard; 1,2,3,4,10,14b-Hexahydro-2-methyl-dibenzo[c,f]pyrazino[1,2-a]azepine hydrochloride; 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]pyryzino[1,2-a]azepine hydrochloride; 2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepinehydrochloride; Mianserin for system suitability, European Pharmacopoeia (EP) Reference Standard; 2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine--hydrogen chloride (1/1); Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, hydrochloride (1:1); Hydron;5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene;chlorideSynonyme